BioLife Solutions Acquires PanTHERA CryoSolutions to Enhance Biopreservation Portfolio

  • Facebook.
  • Twitter.
  • LinkedIn.
  • Print

08:56 AM EDT, 04/07/2025 (MT Newswires) -- BioLife Solutions ( BLFS ) said Monday it acquired privately-held PanTHERA CryoSolutions, a cryopreservation solution developer utilizing proprietary ice recrystallization inhibitor technology, to strengthen its position in biopreservation by enhancing its product portfolio and adding scientific expertise to its management team.

The company said it acquired 90% of PanTHERA shares it does not already own for $9.3 million in cash and 241,355 shares of its common stock.

BioLife also said PanTHERA's shareholders may receive up to $7.2 million in BioLife stock over the next three years, contingent on achieving specific scientific and revenue milestones.

BioLife said it initially invested in PanTHERA in 2020 through its Bioproduction Innovation Accelerator, co-sponsored with Casdin Capital.

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

© 1999-2025 Midnight Trader, Inc. All rights reserved.

  • Facebook.
  • Twitter.
  • LinkedIn.
  • Print
close
Please enter a valid e-mail address
Please enter a valid e-mail address
Important legal information about the e-mail you will be sending. By using this service, you agree to input your real e-mail address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an e-mail. All information you provide will be used by Fidelity solely for the purpose of sending the e-mail on your behalf.The subject line of the e-mail you send will be "Fidelity.com: "

Your e-mail has been sent.
close

Your e-mail has been sent.